assessing clinical meaningfulness with 'time saved' in alzheimer's disease
Published 1 year ago • 372 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
3:10
months saved with treatment as a measure of clinical meaningfulness in ad clinical trials
-
7:43
measuring treatment effect in alzheimer’s disease clinical trials: the ‘time saved’ approach
-
0:49
time saved in alzheimer’s disease in phase iii trial of donanemab
-
1:05:38
webinar on clinical meaningfulness in alzheimer's disease
-
29:51
lecanemab, clinical trials, and the importance of clinical meaningfulness
-
38:52
alzheimer's disease 2021: hot topics in disease prevention and clinical trials
-
7:36
curriculum module 2e: clinical and public health response
-
1:16:19
transforming the alzheimer’s disease journey
-
49:24
dr. jason karlawish - redefining alzheimer's disease: the role of clinical trials
-
1:04:51
denis smirnov - clinicopathologic studies of alzheimer's disease and related dementias
-
6:03
reducing alzheimer’s disease risk video – brigham and women’s hospital
-
32:05
alzheimer's disease, clinical trials, and covid-19 with dr. daniel gillen
-
59:50
detecting pre-symptomatic alzheimer's disease: what we have learned from retinal imaging
-
6:57
optimized anti-aβ vaccination enters clinical trials in alzheimer's disease
-
35:06
david sultzer, md - advances in clinical diagnosis
-
59:38
clinical trials, fad variants, and the etiology of alzheimer’s disease
-
7:15
cognitive assessment tools in alzheimer disease
-
1:00:16
individualized clinical mgt. of patients at risk for alzheimer's dementia - richard isaacson, md
-
12:14
diagnosing alzheimer's disease - on our mind